Clinical trial
Multicenter Open-label, Randomized Clinical Trial to Assess the Safety and Efficacy of Echinaforce® Junior Tablets in Two Dosages for the Therapy of Common Cold Symptoms in Children (4-12 Years)
NCT02198391 is registered in ClinicalTrials.gov with A. Vogel AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter Open-label, Randomized Clinical Trial to Assess the Safety and Efficacy of Echinaforce® Junior Tablets in Two Dosages for the Therapy of Common Cold Symptoms in Children (4-12 Years)
- Lead sponsor
- A. Vogel AG
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 15, 2014
- Completion date
- August 7, 2015
- Enrollment
- 79 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.